Drugs / Adenovirus/PSA Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00583752 | Dec 2007 → Dec 2020 | prostate carcinoma | David M Lubaroff | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Adenovirus/PSA Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00583752 ↗ |
| Modality | Vaccine | “Adenovirus/PSA Vaccine” NCT00583752 ↗ |
| Route | Subcutaneous | “subcutaneously” NCT00583752 ↗ |